Ameriprise Financial Inc Spring Works Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 797,877 shares of SWTX stock, worth $28.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

797,877

Previous 708,383 12.63%

Holding current value

$28.4 Million

Previous $26.7 Million 4.2%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$32.04 - $42.76 $2.87 Million - $3.83 Million	89,494 Added 12.63%	797,877 $25.6 Million
Q2 2024 Aug 14, 2024	BUY	$36.06 - $47.62 $5.44 Million - $7.18 Million	150,762 Added 27.04%	708,383 $26.7 Million
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $1.36 Million - $1.96 Million	37,366 Added 7.18%	557,621 $27.4 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $5.6 Million - $11 Million	295,530 Added 131.51%	520,255 $19 Million
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $35,697 - $48,450	1,544 Added 0.69%	224,725 $5.2 Million
Q2 2023 Aug 14, 2023	SELL	$23.15 - $32.71 $663,594 - $937,632	-28,665 Reduced 11.38%	223,181 $5.85 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $1.77 Million - $2.41 Million	70,850 Added 39.14%	251,846 $6.48 Million
Q4 2022 Feb 14, 2023	BUY	$21.73 - $28.72 $817,265 - $1.08 Million	37,610 Added 26.23%	180,996 $4.71 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $3.46 Million - $5.69 Million	143,386 New	143,386 $4.09 Million
Q1 2022 May 16, 2022	SELL	$48.97 - $65.46 $9.58 Million - $12.8 Million	-195,727 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $62,201 - $88,505	-1,167 Reduced 0.59%	195,727 $12.1 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $54,827 - $77,227	875 Added 0.45%	196,894 $12.5 Million
Q2 2021 Aug 16, 2021	BUY	$67.45 - $85.63 $226,564 - $287,631	3,359 Added 1.74%	196,019 $16.2 Million
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $457,848 - $658,218	-7,033 Reduced 3.52%	192,660 $14.2 Million
Q4 2020 Feb 12, 2021	BUY	$48.36 - $77.92 $1.25 Million - $2.02 Million	25,894 Added 14.9%	199,693 $14.5 Million
Q3 2020 Nov 16, 2020	SELL	$36.14 - $51.99 $46,620 - $67,067	-1,290 Reduced 0.74%	173,799 $8.29 Million
Q2 2020 Aug 14, 2020	BUY	$22.98 - $48.57 $947,649 - $2 Million	41,238 Added 30.81%	175,089 $7.36 Million
Q1 2020 May 15, 2020	SELL	$20.44 - $41.21 $763,147 - $1.54 Million	-37,336 Reduced 21.81%	133,851 $3.61 Million
Q4 2019 Feb 14, 2020	BUY	$17.74 - $39.52 $94,465 - $210,444	5,325 Added 3.21%	171,187 $6.59 Million
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $3.12 Million - $4.61 Million	165,862 New	165,862 $3.59 Million

Others Institutions Holding SWTX

# of Institutions

237

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.22B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Spring Works Therapeutics, Inc. Transaction History